| abstract |
Disclosed is a diaminoalkane aspartic protease inhibitor. Presently, diaminoalkanes of formula I have been discovered and they bind to aspartic proteases that are orally active and inhibit their activity. They are useful in the treatment or amelioration of diseases associated with high levels of aspartic protease activity. The invention also relates to a method of using a compound of formula I in ameliorating or treating an aspartic protease activity-related disease in a subject in need thereof, the method comprising: Administering an effective amount. [Selection figure] None |